IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Imeik Technology Development Co.,Ltd. Stock
Equities
300896
CNE100004868
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 214.8 CNY | -1.38% |
|
+6.06% | +2.17% |
| Apr. 24 | Imeik Technology Development Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 20 | Imeik Technology Development's Profit Rises 47% on Higher Revenue | MT |
| Sales 2024 * | 3.91B 540M | Sales 2025 * | 5.15B 711M | Capitalization | 64.61B 8.92B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.47B 341M | Net income 2025 * | 3.22B 444M | EV / Sales 2024 * | 15.5 x |
| Net cash position 2024 * | 3.98B 550M | Net cash position 2025 * | 5.89B 814M | EV / Sales 2025 * | 11.4 x |
| P/E ratio 2024 * |
26.2
x | P/E ratio 2025 * |
20.1
x | Employees | 910 |
| Yield 2024 * |
1.53% | Yield 2025 * |
1.91% | Free-Float | 35% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.38% | ||
| 1 week | +6.06% | ||
| Current month | -12.94% | ||
| 1 month | -12.94% | ||
| 3 months | +6.39% | ||
| 6 months | -7.96% | ||
| Current year | +2.17% |
1 week
203.06
223.20
1 month
195.36250.71
Current year
191.13255.71
1 year
188.01391.41
3 years
188.01603.17
5 years
123.41603.17
10 years
123.41603.17
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Feng Shi
CEO | Chief Executive Officer | 50 | 09-12-31 |
Ren Chao Zhang
DFI | Director of Finance/CFO | 46 | 21-10-31 |
| 44 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zhong Chen
CHM | Chairman | 68 | 22-11-16 |
Yu Qun Yu
BRD | Director/Board Member | 59 | 21-07-11 |
Xin Yang Lin
BRD | Director/Board Member | 59 | 16-10-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.03% | 2 M€ | -15.79% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-30 | 214.8 | -1.38% | 2,830,050 |
| 24-04-29 | 217.8 | +2.66% | 4,259,472 |
| 24-04-26 | 212.1 | +1.31% | 3,658,354 |
| 24-04-25 | 209.4 | +1.85% | 2,909,504 |
| 24-04-24 | 205.6 | -0.50% | 2,342,608 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Imeik Technology Development Co Ltd is a China-based company mainly engaged in the research and development, production and sales of biomedical materials. The Company focuses on the development and transformation of biomedical materials, and is committed to the development of biomedicine such as recombinant proteins and peptides. The Company has realized the industrialization of injection-type sodium hyaluronate series products and polydioxanone facial implants, and has established a product technology transformation platform for biomedical materials such as medical chitosan and polylactic acid. The Company's self-developed products are mainly aimed at the repair of fold skin on the face and neck. The clinical applications of its products cover medical cosmetology, surgical repair, and treatment of metabolic diseases. The Company mainly conducts its businesses in the China market.
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
214.8
CNY
Average target price
315.9
CNY
Spread / Average Target
+47.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.17% | 8.93B | |
| +12.37% | 128B | |
| -9.23% | 10.69B | |
| +18.79% | 7.32B | |
| +20.77% | 4.82B | |
| +6.97% | 3.4B | |
| -1.41% | 3.03B | |
| -5.07% | 2.23B | |
| -4.22% | 2.13B | |
| -20.87% | 1.84B |
- Stock Market
- Equities
- 300896 Stock
